Sambhv Steel Tubes Limited (NSE:SAMBHV)
India · Delayed Price · Currency is INR 124.35
-3.44 (-2.69%)
At close: Aug 1, 2025, 3:30 PM IST
SpringWorks Therapeutics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2021 |
Operating Revenue | - | 15,114 | 12,858 | 9,372 | 8,194 | 4,789 | Upgrade |
Other Revenue | - | 53.46 | - | - | 0 | - | Upgrade |
| - | 15,167 | 12,858 | 9,372 | 8,194 | 4,789 | Upgrade | |
Revenue Growth (YoY) | - | 17.96% | 37.19% | 14.38% | 71.09% | 96.76% | Upgrade |
Cost of Revenue | - | 10,645 | 9,223 | 6,989 | 6,325 | 3,893 | Upgrade |
Gross Profit | - | 4,522 | 3,635 | 2,383 | 1,868 | 895.94 | Upgrade |
Selling, General & Admin | - | 884.21 | 676.2 | 445.03 | 206.57 | 137.17 | Upgrade |
Other Operating Expenses | - | 2,040 | 1,356 | 763.03 | 404.54 | 118.55 | Upgrade |
Operating Expenses | - | 3,268 | 2,241 | 1,370 | 711.87 | 315.8 | Upgrade |
Operating Income | - | 1,255 | 1,394 | 1,014 | 1,157 | 580.15 | Upgrade |
Interest Expense | - | -472.94 | -304.29 | -213.83 | -170.46 | -141.58 | Upgrade |
Interest & Investment Income | - | - | 22.95 | 8.7 | 6.85 | 6.87 | Upgrade |
Earnings From Equity Investments | - | -0.01 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | 3.56 | 2.01 | 0.2 | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | -7.77 | 2 | -11.87 | -8.01 | Upgrade |
EBT Excluding Unusual Items | - | 781.79 | 1,108 | 812.62 | 981.24 | 437.43 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 2.68 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -3.25 | -1.65 | -0.83 | - | Upgrade |
Other Unusual Items | - | - | 0.07 | 0.2 | - | - | Upgrade |
Pretax Income | - | 781.79 | 1,108 | 811.17 | 980.42 | 437.43 | Upgrade |
Income Tax Expense | - | 209.14 | 283.26 | 207.34 | 251.18 | 106.58 | Upgrade |
Net Income | - | 572.65 | 824.39 | 603.83 | 729.23 | 330.85 | Upgrade |
Net Income to Common | - | 572.65 | 824.39 | 603.83 | 729.23 | 330.85 | Upgrade |
Net Income Growth | - | -30.54% | 36.53% | -17.20% | 120.42% | 178.00% | Upgrade |
Shares Outstanding (Basic) | 240 | 241 | 218 | 201 | 201 | 201 | Upgrade |
Shares Outstanding (Diluted) | 240 | 241 | 218 | 201 | 201 | 201 | Upgrade |
Shares Change (YoY) | 19.57% | 10.59% | 8.29% | - | - | 1.68% | Upgrade |
EPS (Basic) | - | 2.38 | 3.79 | 3.01 | 3.63 | 1.65 | Upgrade |
EPS (Diluted) | - | 2.38 | 3.79 | 3.01 | 3.63 | 1.65 | Upgrade |
EPS Growth | - | -37.19% | 26.07% | -17.20% | 120.42% | 173.42% | Upgrade |
Free Cash Flow | - | -1,007 | -1,425 | -215.52 | -1,078 | -170 | Upgrade |
Free Cash Flow Per Share | - | -4.18 | -6.55 | -1.07 | -5.37 | -0.85 | Upgrade |
Gross Margin | - | 29.82% | 28.27% | 25.43% | 22.80% | 18.71% | Upgrade |
Operating Margin | - | 8.27% | 10.84% | 10.82% | 14.11% | 12.11% | Upgrade |
Profit Margin | - | 3.78% | 6.41% | 6.44% | 8.90% | 6.91% | Upgrade |
Free Cash Flow Margin | - | -6.64% | -11.08% | -2.30% | -13.15% | -3.55% | Upgrade |
EBITDA | - | 1,598 | 1,601 | 1,172 | 1,257 | 639.7 | Upgrade |
EBITDA Margin | - | 10.54% | 12.45% | 12.51% | 15.34% | 13.36% | Upgrade |
D&A For EBITDA | - | 343.54 | 206.83 | 158.61 | 100.2 | 59.55 | Upgrade |
EBIT | - | 1,255 | 1,394 | 1,014 | 1,157 | 580.15 | Upgrade |
EBIT Margin | - | 8.27% | 10.84% | 10.82% | 14.11% | 12.11% | Upgrade |
Effective Tax Rate | - | 26.75% | 25.57% | 25.56% | 25.62% | 24.37% | Upgrade |
Revenue as Reported | - | 15,167 | 12,894 | 9,390 | 8,260 | 4,802 | Upgrade |
Advertising Expenses | - | - | 68.58 | 3.33 | 1.58 | 0.21 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.